Cone- and rod-mediated dark adaptation impairment in age-related maculopathy.

OBJECTIVE To examine impairment in cone- versus rod-mediated dark adaptation in the parafovea of persons with age-related maculopathy (ARM). DESIGN Cross-sectional. PARTICIPANTS Older adults with ARM at various severity levels from early to advanced (n = 83) and in good retinal health (n = 43), as determined by stereo fundus photographs evaluated with the Age-Related Eye Disease Study severity scale. METHODS Dark adaptation, both cone- and rod-mediated components, was measured with a modified Humphrey Field Analyzer using a target located 12 degrees in the inferior visual field on the vertical meridian, after exposure to a 98% bleach. Information was collected on self-reported problems for activities at night or under dim illumination (Low Luminance Questionnaire [LLQ]) and for activities during daytime conditions (modified National Eye Institute Visual Function Questionnaire [NEI VFQ]). MAIN OUTCOME MEASURES Cone- and rod-mediated parameters of dark adaptation. RESULTS Compared with older adults in normal retinal health, ARM patients had significant impairments in rod-mediated parameters of dark adaptation (rod-cone break, rod slope, rod sensitivity) (P<0.0001), which were increasingly abnormal as disease severity increased. Cone-mediated parameters (cone time constant and cone sensitivity) were not impaired. Low Luminance Questionnaire scores and NEI VFQ scores decreased with increased ARM severity (P = 0.0004 and P = 0.0005, respectively); the percent decrease in LLQ scores as a function of disease severity was larger in magnitude than the percent decrease in NEI VFQ scores. CONCLUSIONS Disturbances in rod-mediated but not cone-mediated dark adaptation in the parafovea at 12 degrees in the inferior field on the vertical meridian are characteristic of ARM even in its early phases.

[1]  C. M. Kemp,et al.  Visual function and rhodopsin levels in humans with vitamin A deficiency. , 1988, Experimental eye research.

[2]  Albert Hofman,et al.  Epidemiology of age-related maculopathy: a review. , 2003, European journal of epidemiology.

[3]  A. Bird,et al.  Dark adaptation in age-related macular degeneration: relationship to the fellow eye , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  Cynthia Owsley,et al.  Photoreceptor degeneration and dysfunction in aging and age-related maculopathy , 2002, Ageing Research Reviews.

[5]  Cynthia Owsley,et al.  Photoreceptor Degeneration in Aging and Age-Related Maculopathy , 2005 .

[6]  B. Brown,et al.  Cone Adaptation in Age‐Related Maculopathy , 1986, American journal of optometry and physiological optics.

[7]  N. Bressler,et al.  Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. , 2000, Investigative ophthalmology & visual science.

[8]  G. R. Jackson,et al.  Delays in rod-mediated dark adaptation in early age-related maculopathy. , 2001, Ophthalmology.

[9]  Cynthia Owsley,et al.  Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. , 2006, Investigative ophthalmology & visual science.

[10]  Cynthia Owsley,et al.  Using nonlinear regression to estimate parameters of dark adaptation , 1999, Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc.

[11]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[12]  A. Eisner,et al.  Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. , 1991, Investigative ophthalmology & visual science.

[13]  A. Hofman,et al.  REVIEW: Epidemiology of age-related maculopathy: a review , 2003, European Journal of Epidemiology.

[14]  F. Ferris,et al.  New visual acuity charts for clinical research. , 1982, American journal of ophthalmology.

[15]  A. Bird,et al.  Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. , 1993, The British journal of ophthalmology.

[16]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.

[17]  C Owsley,et al.  Psychophysical evidence for rod vulnerability in age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.

[18]  T. Lamb,et al.  Molecular basis of dark adaptation in rod photoreceptors , 1998, Eye.

[19]  C. Curcio,et al.  The Alabama Age-Related Macular Degeneration Grading System for donor eyes. , 1998, Investigative ophthalmology & visual science.

[20]  T. Lamb,et al.  The involvement of rod photoreceptors in dark adaptation , 1981, Vision Research.

[21]  C Owsley,et al.  Spare the rods, save the cones in aging and age-related maculopathy. , 2000, Investigative ophthalmology & visual science.

[22]  Cynthia Owsley,et al.  Early age-related maculopathy and self-reported visual difficulty in daily life. , 2002, Ophthalmology.

[23]  A. Bird,et al.  Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. , 1992, Investigative ophthalmology & visual science.

[24]  C A Curcio,et al.  Preservation of ganglion cell layer neurons in age-related macular degeneration. , 2001, Investigative ophthalmology & visual science.

[25]  A. Bird,et al.  Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. , 2004, Investigative ophthalmology & visual science.

[26]  Cynthia Owsley,et al.  Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. , 2006, Investigative ophthalmology & visual science.

[27]  C. M. Kemp,et al.  Rhodopsin levels and retinal function in cats during recovery from vitamin A deficiency. , 1989, Experimental eye research.

[28]  Matthew D. Davis,et al.  The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. , 2005, Archives of ophthalmology.

[29]  Cynthia Owsley,et al.  Aging and dark adaptation , 1999, Vision Research.

[30]  R. Radu,et al.  Isomerization and Oxidation of Vitamin A in Cone-Dominant Retinas A Novel Pathway for Visual-Pigment Regeneration in Daylight , 2002, Neuron.

[31]  R. Hays,et al.  Development of the 25-item National Eye Institute Visual Function Questionnaire. , 2001 .

[32]  S. Jacobson,et al.  Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. , 1986, Ophthalmology.

[33]  S. Sarks,et al.  Ageing and degeneration in the macular region: a clinico-pathological study. , 1976, The British journal of ophthalmology.

[34]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[35]  C. Curcio,et al.  Photoreceptor loss in age-related macular degeneration. , 1996, Investigative ophthalmology & visual science.

[36]  Cynthia Owsley,et al.  Aging and scotopic sensitivity , 1998, Vision Research.

[37]  Algis J Vingrys,et al.  Loss of cone function in age-related maculopathy. , 2003, Investigative ophthalmology & visual science.

[38]  T. Lamb,et al.  Dark adaptation and the retinoid cycle of vision , 2004, Progress in Retinal and Eye Research.

[39]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[40]  M. Lavail Analysis of neurological mutants with inherited retinal degeneration. Friedenwald lecture. , 1981, Investigative ophthalmology & visual science.

[41]  Ronald Klein,et al.  A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.

[42]  J. Dowling,et al.  VITAMIN A DEFICIENCY AND NIGHT BLINDNESS. , 1958, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[44]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[45]  Philip J Rosenfeld,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[46]  P T de Jong,et al.  Histologic features of the early stages of age-related macular degeneration. A statistical analysis. , 1992, Ophthalmology.

[47]  W. Stark,et al.  Photoreceptor recovery in retinoid-deprived rats after vitamin A replenishment. , 1993, Experimental Eye Research.

[48]  E. Pugh Rhodopsin flash photolysis in man. , 1975, The Journal of physiology.

[49]  Leslie Hyman,et al.  A Simplified Severity Scale for Age-Related Macular Degeneration , 2005 .